Atlas Trials

Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk

Clinical trial NCT01702207 · COMPLETED

Trial details

NCT number
NCT01702207
Sponsor
University of Saskatchewan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
ImmunosuppressionCardiovascular DiseasesKidney Transplantation
Start date
2012-10-01
Primary completion
2017-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.